Organ Preservation Market Analysis And Forecast To 2031: By Organ Type (Kidneys, Liver, Lung, Heart), By Preservation Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Solution (University of Wisconsin (UW), Custodial HTK, Perfadex) And Region

The global organ preservation market was valued at USD 226.3 million in 2021 and it is anticipated to grow up to USD 444.3 million by 2031, at a CAGR of 7.0% during the forecast period.

Organ preservation is basically a procedure under which organs donated for transplantation are stored and preserved under proper temperature and surroundings. This preservation process generally involves flushing the organ with specific preservation solution dependent on the requirements and storing them on the basis of different techniques as required by the organ.

Global Organ Preservation Market Scope and Report Structure

Report Attribute Details
Market Size in 2021$226.3 mn
Market Size in 2031$444.3 mn
Growth Rate (2021-31)7.0 %
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments Covered

Organ Type, Preservation Technique, Solution, and Region
Key CompaniesParagonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US)
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

Growing geriatric population and subsequent growth in cases of multiple organ failure will positively boost the overall industry expansion. Multiple organ failure is among the most common causes of death in ICUs, mainly caused by sepsis. It is estimated that 26–50% of patients diagnosed with sepsis develop acute renal failure, and up to 20% show acute respiratory failure (Source: Society of Critical Care Medicine). The elderly are at a higher risk of acute renal failure due to an age-related decline in the glomerular filtration rate and the renal plasma flow. Diabetes also increases the vulnerability to these conditions and multiple organ failure. Diseases such as tuberculosis and liver cirrhosis are more common among geriatric individuals and may make it necessary for individuals to undergo organ transplants. According to the Organ Procurement and Transplantation Network, the growth of the geriatric population has a large impact on the number of organ transplantation procedures carried out, as the number of older people receiving organ transplants has grown. For instance, the US observed an increase in the number of organ transplants in the above-65 age group—from 8,691 in 2019 to 8,895 in 2021. As a result, the growth in this population segment, given its high susceptibility to conditions causing organ failure, will be a key driver of market growth

Market Restraints and Challenges

High cost of organ transplantation may impede the market growth. Organ transplantation is a resource-intensive procedure involving highly paid doctors and surgeons, expensive transportation, and pricey drugs that make it expensive. The charges associated with inpatient care, organ procurement, preservation, post-operative recipient care, and anti-rejection medication increase the overall cost. Patients also need to incur additional costs of traveling, lodging, meals, hospital visits, and other medical testing expenditures for evaluation or follow-ups scheduled at the transplant center for an advised time period of medical supervision. For low-income patients, such expenses directly compete with expenditure on necessities such as food, clothing, and shelter, which often renders organ transplantation procedures inaccessible without external aid. Organ transplantation is highly inequitable, but governments could promote more low-cost interventions or provide financial aid for high-cost surgeries, especially for low-income patients. Thus, the high cost of transplant procedures is one of the major factors restricting the growth of the organ preservation market. However, the cost of organ transplants performed in China and India is comparatively lower than in developed nations, encouraging medical tourism to these countries.

Global Organ Preservation Market Segmental Overview

The report analyses the global organ preservation market based on Organ Type, Preservation Technique, Solution, and region.

Global Organ Preservation Market by Organ Type

Based on organ type, it is segmented into kidneys, liver, lung, heart and others. Among these, removable brace segment accounted for significant market share in 2021. The kidney segment held the largest market share in 2019. Increasing cases of kidney failures and number of kidney transplant procedures across the globe are the major factors influencing the segment growth. According to a report published by the NHS in 2019, in the U.S. around 37.00 million patients suffer from chronic kidney disease and almost 726,000 suffer from end-stage renal disease every year. Various awareness campaign related to the benefits of kidney transplant is also anticipated to promote segment growth. For instance, NHS launched ‘Advancing American Kidney Health’ Initiative with an aim to improve the lives of patients suffering from kidney disease in the U.S.

Global Organ Preservation Market by Preservation Technique

Based on preservation technique, it is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion and others. Among them, normothermic machine perfusion segment is expected to experience the fastest growth rate during the forecast period. In this technique, the organ is provided with sufficient nutrition and oxygen that enables aerobic metabolism. It also helps to provide better transplantation outcomes and reduces the chance of post-transplantation side effects. It is majorly used for liver preservation but is also allows efficient preservation of other organs as well. Therefore, such advantages are expected to promote market growth over the forecast period.

Global Organ Preservation Market by Solution

Based on solution, it is segmented into university of wisconsin (UW), custodial HTK, perfadex, and others. Perfadex segment is anticipated to witness the fastest CAGR over the forecast period. This solution is specifically formulated to preserve the integrity and function of organs that are rich in endothelium at the time of cold ischemic storage and flushing before reperfusion and transplantation. This solution is majorly used for lung preservation but can be used to preserve other organs as well. Therefore, such advantages are anticipated to promote segment growth over the forecast period.

Geographical Analysis of Global Organ Preservation Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America held the largest share in the market. Rising acceptance of innovative healthcare technologies, high prevalence of chronic kidney diseases and heart failure, better reimbursement policies, and increasing investments for improving healthcare infrastructure are the major factors promoting the growth. Furthermore, rising geriatric population and an increasing number of organ transplantation procedures are also expected to promote the regional market growth.

Major Players in the Global Organ Preservation Market

The key players in the market are Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US),Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), and Waters Medical Systems (US), among others.

COVID-19 Impact

The coronavirus disease has had an impact on all facets of healthcare, including the execution of life-saving procedures like organ transplantation by altering the process of organ donation and recovery. The spread of COVID-19 has profoundly impacted organ donation and transplantation worldwide. It has disrupted these actions and significantly reduced donation and transplant activities across the globe, leading to a decline in the demand for organ preservation products. In many countries, transplants from deceased donors were limited to only urgent situations and transplants from living donations were put on hold during the period of the outbreak. This resulted in lost opportunities for a large number of vulnerable patients on transplant waiting lists. The pandemic has also resulted in a decrease in the number of potential deceased organ donors, saturation of healthcare systems and ICU capacities, limited access to donor and recipient testing for the infection, and challenges in travel/transport logistics for retrieval teams and donated organs.

Recent Developments
  • In August 2022, Paragonix Technologies, Inc. is announcing a major milestone of preserving over 2,000 donor organs, providing transplant centers Advanced Organ Preservation (AOPT) technology and a nationwide clinical support network.
  • In April 2022, TransMedics announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its OCS™ Heart System for use with organs from donors after circulatory death (DCD).
  • In December 2021, XVIVO Perfusion partnered with Contatti Medical (Brazil) to expand its business and gain access to a comprehensive network of transplantation centers in Latin America’s largest country, Brazil.
  • In October 2021, Paragonix Technologies launched the LIVERguard Donor Liver Preservation System in both the US and Europe. This strategy expanded Paragonixs’ product offerings and strengthened their geographic presence.
  • In July 2021, Institut Georges Lopez (Igl) (France) expanded its presence by setting up a manufacturing facility in Cheyyar, Tamil Nadu, India, for manufacturing medical devices and solutions for flushing and preservation of organs.
Frequently Asked Questions

Q1. How big is the orthopedic braces & supports market?

Ans. The global organ preservation market size was USD 226.3 million in 2021 and is anticipated to reach USD 444.3 million in 2031, growing at a rate of 7.0% from 2022 to 2031.

Q2. What is the organ preservation market growth rate?

Ans. The growth rate of the organ preservation market is 7.0%.

Q3. Which region holds a major market share for the sepsis diagnostics market?

Ans. North America holds a major market share of the organ preservation market in 2021.

Q4. Which segment accounted for the largest organ preservation market share?

Ans. By end user, the healthcare segment accounted for the largest organ preservation market share.

Q5. Who are the key players in the orthopedic braces & supports market?

Ans. The global organ preservation market report includes players such as Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), and Waters Medical Systems (US), among others.

Q6. What are the factors driving the organ preservation market growth?

Ans. The major factors driving the growth of the market are the increasing cases of organ failure across the globeQ7. What are the key growth strategies of organ preservation market players?

Ans. The key growth strategies of organ preservation market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the organ preservation market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the organ preservation market during the forecast period.

 

Table of Contents

Chapter 1. Market Introduction

1.1. Objectives of The Study
1.2. Market Definition And Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary

2.1. Summary
2.2. Key Highlights of The Market

Chapter 3. Organ Preservation Market Outlook

3.1. Organ Preservation Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. Pestle Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of The Russia And Ukraine War on The Organ Preservation Market

Chapter 4. The Economic Impact of COVID-19

4.1. Overall Impact of COVID-19
4.2. Impact of COVID-19 on The Organ Preservation Market
4.3. Economic Impact Analysis

Chapter 5. Organ Preservation Market by Organ Type

5.1. Market Overview
5.2. Kidneys
5.2.1. Market Size And Forecast, 2021-2031 ($Million)
5.2.2. Market Size And Forecast, By Region, 2021-2031 ($Million)
5.3. Liver
5.3.1. Market Size And Forecast, 2021-2031 ($Million)
5.3.2. Market Size And Forecast, By Region, 2021-2031 ($Million)
5.4. Lung
5.4.1. Market Size And Forecast, 2021-2031 ($Million)
5.4.2. Market Size And Forecast, By Region, 2021-2031 ($Million)
5.5. Heart
5.5.1. Market Size And Forecast, 2021-2031 ($Million)
5.5.2. Market Size And Forecast, By Region, 2021-2031 ($Million)
5.6. Others
5.6.1. Market Size And Forecast, 2021-2031 ($Million)
5.6.2. Market Size And Forecast, By Region, 2021-2031 ($Million)

Chapter 6. Organ Preservation Market by Preservation Technique

6.1. Market Overview
6.2. Static Cold Storage
6.2.1. Market Size And Forecast, 2021-2031 ($Million)
6.2.2. Market Size And Forecast, By Region, 2021-2031 ($Million)
6.3. Hypothermic Machine Perfusion
6.3.1. Market Size And Forecast, 2021-2031 ($Million)
6.3.2. Market Size And Forecast, By Region, 2021-2031 ($Million)
6.4. Normothermic Machine Perfusion
6.4.1. Market Size And Forecast, 2021-2031 ($Million)
6.4.2. Market Size And Forecast, By Region, 2021-2031 ($Million)
6.5. Others
6.5.1. Market Size And Forecast, 2021-2031 ($Million)
6.5.2. Market Size And Forecast, By Region, 2021-2031 ($Million)

Chapter 7. Organ Preservation Market By Solution

7.1. Market Overview
7.2. University of Wisconsin (UW)
7.2.1. Market Size And Forecast, 2021-2031 ($Million)
7.2.2. Market Size And Forecast, By Region, 2021-2031 ($Million)
7.3. Custodial HTK
7.3.1. Market Size And Forecast, 2021-2031 ($Million)
7.3.2. Market Size And Forecast, By Region, 2021-2031 ($Million)
7.4. Perfadex
7.4.1. Market Size And Forecast, 2021-2031 ($Million)
7.4.2. Market Size And Forecast, By Region, 2021-2031 ($Million)
7.5. Others
7.5.1. Market Size And Forecast, 2021-2031 ($Million)
7.5.2. Market Size And Forecast, By Region, 2021-2031 ($Million)

Chapter 8. Organ Preservation Market , by Region

8.1. Overview
8.2. North America
8.2.1. Key Market Trends And Opportunities
8.2.2. North America Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.2.3. North America Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.2.4. North America Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.2.5. North America Organ Preservation Market Size And Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.2.6.2. The U.S. Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.2.6.3. The U.S. Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.2.7. Canada
8.2.7.1. Canada Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.2.7.2. Canada Organ Preservation Market Size And Forecast by Preservation Technique Concentrators, 2021-2031, ($Million)
8.2.7.3. Canada Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.2.8.2. Mexico Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.2.8.3. Mexico Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.3. Europe
8.3.1. Key Market Trends And Opportunities
8.3.2. Europe Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.3.3. Europe Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.3.4. Europe Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.3.5. Europe Organ Preservation Market Size And Forecast by Country, 2021-2031, ($Million)
8.3.5.1. Germany
8.3.5.2. Germany Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.3.5.3. Germany Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.3.5.4. Germany Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.3.6. France
8.3.6.1. France Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.3.6.2. France Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.3.6.3. France Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.3.7. U.K
8.3.7.1. U.K. Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.3.7.2. U.K. Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.3.7.3. U.K. Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.3.8. Spain
8.3.8.1. Spain Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.3.8.2. Spain Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.3.8.3. Spain Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.3.9. Italy
8.3.9.1. Italy Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.3.9.2. Italy Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.3.9.3. Italy Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.3.10. Russia
8.3.10.1. Russia Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.3.10.2. Russia Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.3.10.3. Russia Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.3.11.2. Rest of Europe Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.3.11.3. Rest of Europe Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends And Opportunities
8.4.2. Asia-Pacific Organ Preservation Market Size And Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.4.4. Asia-Pacific Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.4.5. China
8.4.5.1. China Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.4.5.2. China Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.4.5.3. China Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.4.6. India
8.4.6.1. India Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.4.6.2. India Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.4.6.3. India Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.4.7. Japan
8.4.7.1. Japan Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.4.7.2. Japan Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.4.7.3. Japan Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.4.8. South Korea
8.4.8.1. South Korea Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.4.8.2. South Korea Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.4.8.3. South Korea Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.4.9. Rest of APAC
8.4.9.1. Rest of APAC Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.4.9.2. Rest of APAC Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.4.9.3. Rest of APAC Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.5. Rest of The World
8.5.1. Key Market Trends And Opportunities
8.5.2. Rest of The World Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.5.3. Rest of The World Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.5.4. Rest of The World Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.5.5. Rest of The World Organ Preservation Market Size And Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.5.6.2. Latin America Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.5.6.3. Latin America Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.5.7.2. Middle East Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.5.7.3. Middle East Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)
8.5.8. Africa
8.5.8.1. Africa Organ Preservation Market Size And Forecast by Organ Type, 2021-2031, ($Million)
8.5.8.2. Africa Organ Preservation Market Size And Forecast by Preservation Technique, 2021-2031, ($Million)
8.5.8.3. Africa Organ Preservation Market Size And Forecast by Solution, 2021-2031, ($Million)

Chapter 9. Competitive Landscape

9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Testing Type Development
9.3.2. Chemical-based Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, And Collaborations
9.3.5. Mergers And Acquisitions

Chapter 10. Company Profiles

10.1. Paragonix Technologies (US)
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Chemical-based offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. XVIVO Perfusion AB (Sweden)
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Chemical-based offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Dr. Franz Köhler Chemie GmbH (Germany)
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Chemical-based offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Essential Pharmaceuticals, LLC (US)
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Chemical-based offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. TransMedics (US)
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Chemical-based offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. OrganOx Limited (UK)
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Chemical-based offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. 21st Century Medicine (US)
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Chemical-based offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Shanghai Genext Medical Technology (China)
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Chemical-based offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Bridge to Life Limited (US)
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Chemical-based offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Waters Medical Systems (US)
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Chemical-based offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis
*The List of Company Is Subject To Change During The Final Compilation of The Report

Global Organ Preservation Market Segmentation

By Organ Type

  • Kidneys
  • Liver
  • Lung
  • Heart
  • Others

By Preservation Techniques

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
  • Others

By Solution

  • University of Wisconsin (UW)
  • Custodial HTK
  • Perfadex
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Travel Vaccines are immunizations specifically designed for individuals…
Viral clearance is the process by which a…
The global Electrophysiology Ablation Catheters market was valued…
Digital Therapeutics is an emerging field that uses…
A medical swab is a piece of cotton…
A Well-Being Platform is a comprehensive digital tool…
The global protein A resin market was valued…
Needle holders are medical instruments used to hold…
A polymer-based prefilled syringe (PPS) is a type…
The global resuscitation devices market was valued at…